Document is current
Any future updates will be listed below
-
Authors
MacKinnon, Madison https://orcid.org/0000-0002-5041-0249
To, Teresa
Ramsey, Clare
Lemière, Catherine
Lougheed, M. Diane
-
Funding
Funding for this research was provided by:
Faculty of Health Sciences, Queen's University
Workers Compensation Board of Manitoba
- License Information
-
More Information
Article History
Received: 6 April 2020
Accepted: 29 July 2020
First Online: 6 August 2020
Ethics approval
: Not applicable.
: Not applicable.
: In the past 3 years, MDL has received: grants outside the submitted work paid directly to Queen’s University from The Lung Association-Ontario, Ontario Thoracic Society, the Government of Ontario’s Innovation Fund, AllerGen NCE, Queen’s University, the Canadian Institutes of Health Research (sub-grant from the University of Ottawa), AstraZeneca, GlaxoSmithKline, Hoffman LaRoche, Janssen, and Novartis; and honoraria from the The Lung Association-Ontario for preparation and review of educational materials, AstraZeneca for participation in the Precision Program Advisory Board, and the Canadian Thoracic Society for co-development and co-presentation of a severe asthma continuing education program. All other authors declare they have no competing interests.
